Stay updated on Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed older entries including the funding status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and current NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded Show glossary and updated QC metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removed older labels such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe changes are minor revision notes: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedFooter updates: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab SC 100mg in Severe Eosinophilic Asthma Clinical Trial page.